RightFit
RecruitingNot applicable

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to Enhance MRI Diagnostic Capabilities in Prostate Cancer

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
No age limits stated
Sex
Male only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: MRI scans, Biopsies

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Patients who have agreed to undergo an MRI and subsequent prostate needle biopsy will be approached to participate in the trial."
  • "Validate RSI-MRI imaging biomarker performance using a prospective clinical trial."
  • "Calibrate the RSM values across different MRI scanner manufacturers."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

The researchers hope to learn if specific types of MRI software and techniques can help improve early prostate cancer detection at time of a MRI-guided prostate biopsy.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Official eligibility criteria

Inclusion Criteria: * Selected to undergo an MRI-fusion prostate needle biopsy of the prostate. * Able to provide informed consent Exclusion Criteria: * prior diagnosis of prostate cancer (Grade Group \>1) * metastatic prostate cancer * prior prostate cancer treatment * contraindication to prostate biopsy (e.g., on anticoagulation that cannot be safely discontinued) * inability to undergo MRI (e.g., too large to be accommodated in a scanner or with an implant incompatible with MRI). * Bilateral hip replacement * Unable to provide informed consent.

Study sites (1)

CA